Skip to main content
Top
Published in: Clinical Rheumatology 3/2016

01-03-2016 | Case Based Review

Severe hyperferritinemia—a clue for severe hepatitis in a patient with adult-onset Still’s disease

Authors: Rema Bishara, Yolanda Braun-Moscovici, Amir Dagan, Kohava Toledano, Tarek Saadi, Edmond Sabo, Alexandra Balbir-Gurman

Published in: Clinical Rheumatology | Issue 3/2016

Login to get access

Abstract

A 19-year old previously healthy man developed the adult-onset Still’s disease (AOSD) with high ferritin levels. Corticosteroids induced clinical remission with resolution of fever, arthritis, and rash. While tapering corticosteroids, the patient developed severe liver enzymes elevation, very high ferritin levels and, subsequently, acute liver failure. After other causes of liver disease (infections, metabolic, autoimmune hepatitis, lymphoma, and hemophagocytosis) were excluded, severe hepatitis was attributed to AOSD itself. Cyclosporine induced rapid normalization of liver enzymes and reduction in ferritin levels. Severe hepatitis and very high ferritin levels could be the only manifestation of disease activity in AOSD; therefore, monitoring of liver enzymes and ferritin levels is recommended even after resolution of the clinical symptoms of AOSD. Prompt initiation of cyclosporine can improve liver function and prevent progression to liver failure.
Literature
1.
go back to reference Efthimiou P, Georgy S (2006) Pathogenesis and management of adult-onset Still’s disease. Semin Arthritis Rheum 36:144–152CrossRefPubMed Efthimiou P, Georgy S (2006) Pathogenesis and management of adult-onset Still’s disease. Semin Arthritis Rheum 36:144–152CrossRefPubMed
2.
go back to reference Priori R, Barone F, Alessandri C et al (2011) Markedly increased IL-18 liver expression in adult-onset Still’s disease-related hepatitis. Rheumatology (Oxford) 50:776–780CrossRef Priori R, Barone F, Alessandri C et al (2011) Markedly increased IL-18 liver expression in adult-onset Still’s disease-related hepatitis. Rheumatology (Oxford) 50:776–780CrossRef
3.
go back to reference Evensen KJ, Swaak TJ, Nossent JC (2007) Increased ferritin response in adult Still’s disease: specificity and relationship to outcome. Scand J Rheumatol 36:107–110CrossRefPubMed Evensen KJ, Swaak TJ, Nossent JC (2007) Increased ferritin response in adult Still’s disease: specificity and relationship to outcome. Scand J Rheumatol 36:107–110CrossRefPubMed
4.
go back to reference Meijvis SC, Endeman H, Geers AB, ter Borg EJ (2007) Extremely high serum ferritin levels as diagnostic tool in adult-onset Still’s disease. Neth J Med 65:212–214PubMed Meijvis SC, Endeman H, Geers AB, ter Borg EJ (2007) Extremely high serum ferritin levels as diagnostic tool in adult-onset Still’s disease. Neth J Med 65:212–214PubMed
5.
go back to reference Takahashi A, Abe K, Yokokawa J et al (2010) Clinical features of liver dysfunction in collagen diseases. Hepatol Res 40:1092–1097CrossRefPubMed Takahashi A, Abe K, Yokokawa J et al (2010) Clinical features of liver dysfunction in collagen diseases. Hepatol Res 40:1092–1097CrossRefPubMed
6.
go back to reference Andrès E, Kurtz JE, Perrin AE et al (2003) Retrospective monocentric study of 17 patients with adult Still’s disease, with special focus on liver abnormalities. Hepatogastroenterology 50:192–195PubMed Andrès E, Kurtz JE, Perrin AE et al (2003) Retrospective monocentric study of 17 patients with adult Still’s disease, with special focus on liver abnormalities. Hepatogastroenterology 50:192–195PubMed
7.
go back to reference Zhu G, Liu G, Liu Y, Xie Q, Shi G (2009) Liver abnormalities in adult onset Still’s disease: a retrospective study of 77 Chinese patients. J Clin Rheumatol 15:284–288CrossRefPubMed Zhu G, Liu G, Liu Y, Xie Q, Shi G (2009) Liver abnormalities in adult onset Still’s disease: a retrospective study of 77 Chinese patients. J Clin Rheumatol 15:284–288CrossRefPubMed
8.
go back to reference Taccone FS, Lucidi V, Donckier V, Bourgeois N, Decaux G, Vandergheynst F (2008) Fulminant hepatitis requiring MARS and liver transplantation in a patient with Still’s disease. Eur J Intern Med 19:e26–e28CrossRefPubMed Taccone FS, Lucidi V, Donckier V, Bourgeois N, Decaux G, Vandergheynst F (2008) Fulminant hepatitis requiring MARS and liver transplantation in a patient with Still’s disease. Eur J Intern Med 19:e26–e28CrossRefPubMed
9.
go back to reference Meckenstock R, Therby A, Gibault-Genty G, Khau D, Monnier S, Greder-Belan A (2012) Adult-onset Still’s disease revealed by perimyocarditis and a concomitant reactivation of an EBV infection. BMJ Case Rep 2012 Meckenstock R, Therby A, Gibault-Genty G, Khau D, Monnier S, Greder-Belan A (2012) Adult-onset Still’s disease revealed by perimyocarditis and a concomitant reactivation of an EBV infection. BMJ Case Rep 2012
10.
go back to reference Izumikawa K, Morinaga Y, Kondo A et al (2007) Adult Still’s disease associated with cytomegalovirus infection. J Infect Chemother 13:114–117CrossRefPubMed Izumikawa K, Morinaga Y, Kondo A et al (2007) Adult Still’s disease associated with cytomegalovirus infection. J Infect Chemother 13:114–117CrossRefPubMed
11.
go back to reference Amenomori M, Migita K, Miyashita T, Yoshida S, Ito M, Eguchi K, Ezaki H (2005) Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still’s disease. Clin Exp Rheumatol 23:100–102PubMed Amenomori M, Migita K, Miyashita T, Yoshida S, Ito M, Eguchi K, Ezaki H (2005) Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still’s disease. Clin Exp Rheumatol 23:100–102PubMed
12.
go back to reference Longo G, Luppi M, Bertesi M, Ferrara L, Torelli G, Emilia G (1998) Still’s disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection. Clin Infect Dis 26:994–995CrossRefPubMed Longo G, Luppi M, Bertesi M, Ferrara L, Torelli G, Emilia G (1998) Still’s disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection. Clin Infect Dis 26:994–995CrossRefPubMed
13.
go back to reference Michel M, Duvoux C, Hezode C, Cherqui D (2003) Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still’s disease. J Rheumatol 30:1624–1625PubMed Michel M, Duvoux C, Hezode C, Cherqui D (2003) Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still’s disease. J Rheumatol 30:1624–1625PubMed
15.
go back to reference Maclachlan D, Tyndall A (2000) Acute hepatitis in adult Still’s disease apparently resulting from oral iron substitution—a case report. Clin Rheumatol 19:222–225CrossRefPubMed Maclachlan D, Tyndall A (2000) Acute hepatitis in adult Still’s disease apparently resulting from oral iron substitution—a case report. Clin Rheumatol 19:222–225CrossRefPubMed
16.
go back to reference Diallo A, Mekinian A, Boukari L, Mouas H, Zamy M, Nahon P et al (2013) Severe hepatitis in a patient with adult-onset Still’s disease treated with anakinra. Rev Med Interne 34:168–170CrossRefPubMed Diallo A, Mekinian A, Boukari L, Mouas H, Zamy M, Nahon P et al (2013) Severe hepatitis in a patient with adult-onset Still’s disease treated with anakinra. Rev Med Interne 34:168–170CrossRefPubMed
17.
go back to reference Fujii K, Rokutanda R, Osugi Y, Koyama Y, Ota T (2012) Adult-onset Still’s disease complicated by autoimmune hepatitis: successful treatment with infliximab. Intern Med 51:1125–1128CrossRefPubMed Fujii K, Rokutanda R, Osugi Y, Koyama Y, Ota T (2012) Adult-onset Still’s disease complicated by autoimmune hepatitis: successful treatment with infliximab. Intern Med 51:1125–1128CrossRefPubMed
18.
go back to reference Liu LL, Feng ML, Wang LN, Li XL, Yao L (2010) A case report of successful treatment with plasma exchange for adult-onset Still’s disease with autoimmune hepatitis. J Clin Apher 25:74–76CrossRefPubMed Liu LL, Feng ML, Wang LN, Li XL, Yao L (2010) A case report of successful treatment with plasma exchange for adult-onset Still’s disease with autoimmune hepatitis. J Clin Apher 25:74–76CrossRefPubMed
19.
go back to reference Haider FS, Smith R, Khan S (2008) Primary hepatic lymphoma presenting as fulminant hepatic failure with hyperferritinemia: a case report. J Med Case Reports 2:279CrossRefPubMedCentral Haider FS, Smith R, Khan S (2008) Primary hepatic lymphoma presenting as fulminant hepatic failure with hyperferritinemia: a case report. J Med Case Reports 2:279CrossRefPubMedCentral
20.
go back to reference Zhang XH, Han YM, Wang WW, Cheng H, Zhu KJ (2012) Hemophagocytic syndrome secondary to adult-onset Still's disease but very similar to lymphoma. Int J Clin Exp Pathol 5:377–381PubMedPubMedCentral Zhang XH, Han YM, Wang WW, Cheng H, Zhu KJ (2012) Hemophagocytic syndrome secondary to adult-onset Still's disease but very similar to lymphoma. Int J Clin Exp Pathol 5:377–381PubMedPubMedCentral
21.
go back to reference Yamanaka J, Saito S, Kuroda N, Hirano T, Fujimoto J (2003) Successful living related liver transplantation for adult Still’s disease. J Gastroenterol Hepatol 18:1109–1110CrossRefPubMed Yamanaka J, Saito S, Kuroda N, Hirano T, Fujimoto J (2003) Successful living related liver transplantation for adult Still’s disease. J Gastroenterol Hepatol 18:1109–1110CrossRefPubMed
22.
go back to reference Takami A, Nakao S, Miyamori H et al (1995) Adult-onset Still’s disease with submassive hepatic necrosis. Intern Med 34:89–91CrossRefPubMed Takami A, Nakao S, Miyamori H et al (1995) Adult-onset Still’s disease with submassive hepatic necrosis. Intern Med 34:89–91CrossRefPubMed
23.
go back to reference McFarlane M, Harth M, Wall WJ (1997) Liver transplant in adult Still’s disease. J Rheumatol 24:2038–2041PubMed McFarlane M, Harth M, Wall WJ (1997) Liver transplant in adult Still’s disease. J Rheumatol 24:2038–2041PubMed
24.
go back to reference Dino O, Provenzano G, Giannuoli G, Sciarrino E, Pouyet M, Pagliaro L (1996) Fulminant hepatic failure in adult onset Still’s disease. J Rheumatol 23:784–785PubMed Dino O, Provenzano G, Giannuoli G, Sciarrino E, Pouyet M, Pagliaro L (1996) Fulminant hepatic failure in adult onset Still’s disease. J Rheumatol 23:784–785PubMed
25.
go back to reference Assy N, Schlesinger S, Hussein O (2001) Acute hepatitis with extremely high ferritin levels and Still’s disease. J Hepatol 35:830–831CrossRefPubMed Assy N, Schlesinger S, Hussein O (2001) Acute hepatitis with extremely high ferritin levels and Still’s disease. J Hepatol 35:830–831CrossRefPubMed
26.
go back to reference Omagari K, Matsunaga Y, Yamashita H et al (2003) Successful treatment with cyclosporin in adult-onset Still disease manifesting as acute hepatitis with marked hyperferritinemia. Am J Med Sci 326:148–151CrossRefPubMed Omagari K, Matsunaga Y, Yamashita H et al (2003) Successful treatment with cyclosporin in adult-onset Still disease manifesting as acute hepatitis with marked hyperferritinemia. Am J Med Sci 326:148–151CrossRefPubMed
27.
go back to reference Ott SJ, Baron A, Berghaus T, Lamerz R, Beuers U (2003) Liver failure in adult Still’s disease during corticosteroid treatment. Eur J Gastroenterol Hepatol 15:87–90CrossRefPubMed Ott SJ, Baron A, Berghaus T, Lamerz R, Beuers U (2003) Liver failure in adult Still’s disease during corticosteroid treatment. Eur J Gastroenterol Hepatol 15:87–90CrossRefPubMed
28.
go back to reference Ogata A, Kitano M, Yamanaka J et al (2003) Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still’s disease. J Rheumatol 30:1093–1096PubMed Ogata A, Kitano M, Yamanaka J et al (2003) Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still’s disease. J Rheumatol 30:1093–1096PubMed
29.
go back to reference Mylona E, Golfinopoulou S, Samarkos M, Fanourgiakis P, Papadakos V, Skoutelis A (2008) Acute hepatitis in adult Still’s disease during corticosteroid treatment successfully treated with anakinra. Clin Rheumatol 27:659–661CrossRefPubMed Mylona E, Golfinopoulou S, Samarkos M, Fanourgiakis P, Papadakos V, Skoutelis A (2008) Acute hepatitis in adult Still’s disease during corticosteroid treatment successfully treated with anakinra. Clin Rheumatol 27:659–661CrossRefPubMed
30.
go back to reference Thabah MM, Singh KK, Madhavan SM, Gupta R (2008) Adult onset Still’s disease as a cause of acute liver failure. Trop Gastroenterol 29:35–36PubMed Thabah MM, Singh KK, Madhavan SM, Gupta R (2008) Adult onset Still’s disease as a cause of acute liver failure. Trop Gastroenterol 29:35–36PubMed
31.
go back to reference Nagashima T, Aoki Y, Onishi S, Iwamoto M, Okazaki H, Minota S (2008) Steroid-refractory severe hepatic failure in adult onset Still’s disease responding to cyclosporine. Clin Rheumatol 27:1451–1453CrossRefPubMed Nagashima T, Aoki Y, Onishi S, Iwamoto M, Okazaki H, Minota S (2008) Steroid-refractory severe hepatic failure in adult onset Still’s disease responding to cyclosporine. Clin Rheumatol 27:1451–1453CrossRefPubMed
32.
go back to reference Yeh SF, Yang D-H, Hou T-Y, Chang D-M, Kuo S-Y, Chen C-H (2009) Cyclosporine for adult onset Still’s disease flare with hepatic dysfunction. J Med Sci 29:143–146 Yeh SF, Yang D-H, Hou T-Y, Chang D-M, Kuo S-Y, Chen C-H (2009) Cyclosporine for adult onset Still’s disease flare with hepatic dysfunction. J Med Sci 29:143–146
33.
go back to reference Hogan T, Kao KT, Tung J (2011) A rare case of severe acute hepatitis associated with adult-onset Still's disease dramatically improved by high-dose steroid therapy. Gastroenterol Hepatol (NY) 7:841–844 Hogan T, Kao KT, Tung J (2011) A rare case of severe acute hepatitis associated with adult-onset Still's disease dramatically improved by high-dose steroid therapy. Gastroenterol Hepatol (NY) 7:841–844
34.
go back to reference Harmanci Ö, Kav T, Sökmensüer C, Çalgünerı M, Bayraktar Y (2013) Successful management of severe acute liver disease related with adult-onset Still’s disease in a pregnant patient. Turk J Gastroenterol 24:61–64PubMed Harmanci Ö, Kav T, Sökmensüer C, Çalgünerı M, Bayraktar Y (2013) Successful management of severe acute liver disease related with adult-onset Still’s disease in a pregnant patient. Turk J Gastroenterol 24:61–64PubMed
35.
go back to reference Singh B, Biboa J, Musuku S, Patel C, Pugh JL, Boyer TD (2013) Reversal of severe hepatitis with infliximab in adult-onset Still’s disease. Am J Med 126:e3–e4CrossRefPubMed Singh B, Biboa J, Musuku S, Patel C, Pugh JL, Boyer TD (2013) Reversal of severe hepatitis with infliximab in adult-onset Still’s disease. Am J Med 126:e3–e4CrossRefPubMed
36.
go back to reference Mehta B, Efthimiou P (2012) Ferritin in adult-onset Still's disease: just a useful innocent bystander? Int J Inflam 2012:298405PubMedPubMedCentral Mehta B, Efthimiou P (2012) Ferritin in adult-onset Still's disease: just a useful innocent bystander? Int J Inflam 2012:298405PubMedPubMedCentral
37.
go back to reference Lim KB, Schiano TD (2011) Still disease and the liver—an underappreciated association. Gastroenterol Hepatol (NY) 7:844–846 Lim KB, Schiano TD (2011) Still disease and the liver—an underappreciated association. Gastroenterol Hepatol (NY) 7:844–846
38.
go back to reference Fautrel B, Sibilia J, Mariette X, Combe B, Club Rhumatismes et Inflammation (2005) Tumour necrosis factor alpha blocking agents in refractory adult Still’s disease: an observational study of 20 cases. Ann Rheum Dis 64:262–266CrossRefPubMedPubMedCentral Fautrel B, Sibilia J, Mariette X, Combe B, Club Rhumatismes et Inflammation (2005) Tumour necrosis factor alpha blocking agents in refractory adult Still’s disease: an observational study of 20 cases. Ann Rheum Dis 64:262–266CrossRefPubMedPubMedCentral
39.
go back to reference Benucci M, Li GF, Del Rosso A, Manfredi M (2005) Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still’s disease: the first case report. Clin Exp Rheumatol 23:733PubMed Benucci M, Li GF, Del Rosso A, Manfredi M (2005) Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still’s disease: the first case report. Clin Exp Rheumatol 23:733PubMed
40.
go back to reference Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, Weinblatt ME (2002) Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum 46:1171–1176CrossRefPubMed Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, Weinblatt ME (2002) Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum 46:1171–1176CrossRefPubMed
41.
go back to reference De Boysson H, Février J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidence. Clin Rheumatol 32:141–147CrossRefPubMed De Boysson H, Février J, Nicolle A, Auzary C, Geffray L (2013) Tocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidence. Clin Rheumatol 32:141–147CrossRefPubMed
42.
go back to reference Giampietro C, Ridene M, Lequerre T, CRI (Club Rhumatismes et Inflammation) et al (2013) Anakinra in adult-onset Still’s disease: long-term treatment in patients resistant to conventional therapy. Arthritis Care Res (Hoboken) 65:822–826CrossRef Giampietro C, Ridene M, Lequerre T, CRI (Club Rhumatismes et Inflammation) et al (2013) Anakinra in adult-onset Still’s disease: long-term treatment in patients resistant to conventional therapy. Arthritis Care Res (Hoboken) 65:822–826CrossRef
43.
go back to reference Petryna O, Cush JJ, Efthimiou P (2012) IL-1 Trap rilonacept in refractory adult onset Still’s disease. Ann Rheum Dis 71:2056–2057CrossRefPubMed Petryna O, Cush JJ, Efthimiou P (2012) IL-1 Trap rilonacept in refractory adult onset Still’s disease. Ann Rheum Dis 71:2056–2057CrossRefPubMed
44.
go back to reference Kontzias A, Efthimiou P (2012) The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still’s disease. Semin Arthritis Rheum 42:201–205CrossRefPubMed Kontzias A, Efthimiou P (2012) The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still’s disease. Semin Arthritis Rheum 42:201–205CrossRefPubMed
45.
go back to reference Visser K, van der Heijde DM (2009) Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol 27:1017–1025PubMed Visser K, van der Heijde DM (2009) Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol 27:1017–1025PubMed
46.
go back to reference López-Martín C, de la Fuente-Fernández E, Corbatón P, Sánchez MC, Gisbert JP (2011) Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn’s disease. Gastroenterol Hepatol 34:16–19CrossRefPubMed López-Martín C, de la Fuente-Fernández E, Corbatón P, Sánchez MC, Gisbert JP (2011) Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn’s disease. Gastroenterol Hepatol 34:16–19CrossRefPubMed
47.
go back to reference Van Roon EN, Jansen TL, Houtman NM, Spoelstra P, Brouwers JR (2004) Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity. Drug Saf 27:345–352CrossRefPubMed Van Roon EN, Jansen TL, Houtman NM, Spoelstra P, Brouwers JR (2004) Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity. Drug Saf 27:345–352CrossRefPubMed
48.
49.
go back to reference Satapathy SK, Isabel Fiel M, Del Rio MJ, Aloman C, Schiano TD (2010) Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still’s disease. Hepatol Int 5:597–602CrossRefPubMedPubMedCentral Satapathy SK, Isabel Fiel M, Del Rio MJ, Aloman C, Schiano TD (2010) Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still’s disease. Hepatol Int 5:597–602CrossRefPubMedPubMedCentral
50.
go back to reference Marchesoni A, Ceravolo GP, Battafarano N, Rossetti A, Tosi S, Fantini F (1997) Cyclosporin A in the treatment of adult onset Still’s disease. J Rheumatol 24:1582–1587PubMed Marchesoni A, Ceravolo GP, Battafarano N, Rossetti A, Tosi S, Fantini F (1997) Cyclosporin A in the treatment of adult onset Still’s disease. J Rheumatol 24:1582–1587PubMed
Metadata
Title
Severe hyperferritinemia—a clue for severe hepatitis in a patient with adult-onset Still’s disease
Authors
Rema Bishara
Yolanda Braun-Moscovici
Amir Dagan
Kohava Toledano
Tarek Saadi
Edmond Sabo
Alexandra Balbir-Gurman
Publication date
01-03-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2829-2

Other articles of this Issue 3/2016

Clinical Rheumatology 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.